Solid-state transformers in locomotives fed through AC lines: A review and future developments

One of the most important innovation expectation in railway electrical equipment is the replacement of the on-board transformer with a high power converter. Since the transformer operates at line-frequency (i.e., 50 Hz or 16 2/3 Hz), it represents a critical component from weight point of view and, moreover, it is characterized by quite poor efficiency. High power converters for this application are characterized by a medium frequency inductive coupling and are commonly referred as Power Electronic Transformers (PET), Medium Frequency Topologies or Solid-State Transformers (SST). Many studies were carried out and various prototypes were realized until now, however, the realization of such a system has some difficulties, mainly related to the high input voltage (i.e., 25 kV for 50 Hz lines and 15 kV for 16 2/3 Hz lines) and the limited performance of available power electronic switches. The aim of this study is to present a survey on the main solutions proposed in the technical literature and, analyzing pros and cons of these studies, to introduce new possible circuit topologies for this application

Soft-switching cells for Modular Multilevel Converters for efficient grid integration of renewable sources

The Modular Multilevel Converter (MMC) concept is a modern energy conversion structure that stands out for a number of interesting features that opens wide application chances in Power Systems, for example for efficient grid integration of renewable sources. In these high-voltage, high-power application fields, a high efficiency is mandatory. In this regard, an interesting and promising development opportunity could be to make soft-switching the elementary converters of the submodules (cells), half H-bridges or full H-bridges, obtaining at the same time the advantage of increasing the switching frequency. The-Active Resonant Commutated Pole Converter (ARCP) or the Auxiliary Quasi Resonant DC-link Inverter (AQRDCL) soft-switching topologies appear adequate for this purpose. This paper is dedicated to examining these development possibilities

Visualisation analysis for exploring prerequisite relations in textbooks

Building automatic strategies for organising knowledge contained in textbooks has a tremendous potential to enhance meaningful learning. Automatic identification of prerequisite relation (PR) between concepts in a textbook is a well-known way for knowledge structuring, yet it is still an open issue. Our research contributes for better understanding and exploring the phenomenon of PR in textbooks, by providing a collection of visualisation techniques for PR exploration and analysis, that we used for the design of and then the refinement of our algorithm for PR extraction

Gefitinib plus interleukin-2 in advanced non-small cell lung cancer patients previously treated with chemotherapy

The activation of lymphocytes by gefitinib treatment has been described. In this phase II pilot trial, we explored the possible synergism between IL-2 and gefitinib for non-small cell lung cancer (NSCLC) treatment. From September, 2003, to November, 2006, 70 consecutive patients with advanced, progressive NSCLC, previously treated with chemotherapy, received oral gefitinib 250 mg daily. The first 39 patients received gefitinib alone (G group). The other 31 also received subcutaneous IL-2 (GIL-2 group): 1 MIU/m2 (Million International Unit/m2)twice a day on Days 1 and 2, once a day on Days 3, 4, 5 every week for four consecutive weeks with a four-week rest period. Median follow-up was 25.2 months. Grade 3–4 toxicity of gefitinib was represented by skin rash (7%), asthenia/anorexia (6%) and diarrhea (7%); patients treated with IL-2 showed grade 2–3 fever (46%), fatigue (21%) and arthralgia (13%). In the GIL-2 group and G-group, we respectively observed: an overall response rate of 16.1% (6.4% complete response) and 5.1% (only partial response); a disease control rate of 41.9% and 41%; a median time to progression of 3.5 (CI 95% = 3.2–3.8) and 4.1 (CI 95% = 2.6–5.7) months; a median overall survival of 20.1 (CI 95% = 5.1–35.1) and 6.9 (CI 95% = 4.9–8.9) months (p = 0.002); and an actuarial one-year survival rate of 54% and 30%. Skin toxicity (p < 0.001; HR = 0.29; CI 95% = 0.16–0.54) and use of IL-2 (p < 0.001; HR = 0.33; CI 95% = 0.18–0.60) were independently associated with improvement of survival. In this consecutive, non-randomized, series of advanced NSCLC patients, the use of IL-2 increased the efficacy of gefitinib

Extracellular release of the ‘differentiation enhancing factor’, a HMG1 protein type, is an early step in murine erythroleukemia cell differentiation

AbstractDifferentiation enhancing factor (DEF) is a 29 kDa protein expressed in murine erythroleukemia (MEL) cells and active in promoting a significant increase in the rate of hexamethylenebisacetamide induced differentiation of these cells. The factor was recently shown to possess an amino acid sequence identical to that reported for one of the HMG1 proteins, designated as ‘amphoterin’ on the basis of its highly dipolar sequence. In the present study, we have expressed DEF cDNA in an E. coli strain and found that the recombinant protein has functional properties identical to those observed with native DEF. Furthermore, we demonstrate that, following MEL cell stimulation with the chemical inducer, DEF is secreted in large amounts in the extracellular medium. In fact, the N-terminal sequence and the partial amino acid sequence of tryptic peptides from the secreted protein correspond to those of DEF isolated from the soluble fraction of resting MEL cells. These results are indicative for an extracellular localization as the site of action of DEF and suggest a novel function for proteins belonging to the HMG1 family. Finally, the early decay of DEF mRNA, in chemical induced MEL cells, support the hypothesis that the involvement of the enhancing factor occurs and is completed in the early phases of cell differentiation

Stability Analysis of Open-Loop V/Hz Controlled Asynchronous Machines and Two Novel Mitigation Strategies for Oscillations Suppression

Asynchronous machines are always widely used in most industrial applications due to their reliability, flexibility, and manoeuvrability. To achieve variable speed operations, the quite simple open-loop V/Hz control is largely utilized. Under open-loop V/Hz control, the nonlinear interaction is well known to cause current and torque oscillations while operating at low to medium speeds under light loads. This article presents the stability analysis of induction motors at low\u2013medium frequencies under no-load conditions with the V/Hz control. A system representation in the form of state space is discussed, and the region of instability is plotted against the V/f plane. Two novel and refined methods for the mitigation of oscillations in the region of instability are presented. The two proposed algorithms are finally tested and validated through simulation on an inverter-fed induction motor drive system

Induction Motor Field-Oriented Sensorless Control with Filter and Long Cable

In recent years, part of the efforts of the electric drive researcher has been focused on the study of sensorless control algorithms that allow controlling the machine without a speed measure and with ever-fewer measurement devices. This article proposes a possible solution for the submarine application of an asynchronous motor. The motor is designed to drive a petrol pump at a depth of three thousand meters. The motor is fed by an inverter that is located on an offshore platform, and they are connected through a filter and a cable that is 19.74 km long. In this application, it is not suitable to use a speed measurement device; in fact, at this depth it is important to use as few components as possible, in order to increase the system reliability. A control algorithm that only needs available electrical measures is proposed below

Adherence issues related to sublingual immunotherapy as perceived by allergists

Sublingual immunotherapy (SLIT) is a viable alternative to subcutaneous immunotherapy to treat allergic rhinitis and asthma, and is widely used in clinical practice in many European countries. The clinical efficacy of SLIT has been established in a number of clinical trials and meta-analyses. However, because SLIT is self-administered by patients without medical supervision, the degree of patient adherence with treatment is still a concern. The objective of this study was to evaluate the perception by allergists of issues related to SLIT adherence.We performed a questionnaire-based survey of 296 Italian allergists, based on the adherence issues known from previous studies. The perception of importance of each item was assessed by a VAS scale ranging from 0 to 10.Patient perception of clinical efficacy was considered the most important factor (ranked 1 by 54\% of allergists), followed by the possibility of reimbursement (ranked 1 by 34\%), and by the absence of side effects (ranked 1 by 21\%). Patient education, regular follow-up, and ease of use of SLIT were ranked first by less than 20\% of allergists.These findings indicate that clinical efficacy, cost, and side effects are perceived as the major issues influencing patient adherence to SLIT, and that further improvement of adherence is likely to be achieved by improving the patient information provided by prescribers